Reducing the risk of maternal-infant transmission of HIV by attacking the virus

Editorial

M F Rogers et al. N Engl J Med. 1999.

. 1999 Aug 5;341(6):441-3.

doi: 10.1056/NEJM199908053410609.

No abstract available

Comment on

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ. Mofenson LM, et al. N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601. N Engl J Med. 1999. PMID: 10432323 Clinical Trial.
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF. Garcia PM, et al. N Engl J Med. 1999 Aug 5;341(6):394-402. doi: 10.1056/NEJM199908053410602. N Engl J Med. 1999. PMID: 10432324